James B. Weissman, Chief Business Officer at Dicerna Pharmaceuticals Inc (DRNA), sold 1,035 shares at $13.00 ($13K) on 2018-03-19, disclosed to the SEC on 2018-03-21.
Scheduled sale ($13k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DRNA | SELL | 2021-02-08 | $386K | — | Filing → |
| DRNA | SELL | 2021-01-12 | $91K | — | Filing → |
| DRNA | SELL | 2020-12-03 | $220K | — | Filing → |